Diagnostics: Page 16
-
Permission granted by Becton Dickinson
BD raises full-year forecast, sees Q1 strength in pharmacy automation, pre-fillables
The company’s base businesses helped cushion the impact of declining COVID-19 testing demand.
By Susan Kelly • Feb. 2, 2023 -
Retrieved from Siemsens Website on July 01, 2022
Siemens Healthineers forecasts revenue growth to accelerate despite supply chain woes
Lower diagnostics revenue hurt sales in the three months ended Dec. 31.
By Nick Paul Taylor • Feb. 2, 2023 -
Gorodenkoff via Getty Images
Medtech trends in 2023Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound
Companies flush with cash are looking for good investments and innovative products that can reduce procedure costs, industry observers say.
By Peter Green • Jan. 31, 2023 -
Courtesy of University of Illinois/Yongdeok Kim
Researchers create remote-controlled biological robot that could eventually be used in surgery
The design allows the integration of sensors and other components that could eventually equip the robots to detect biomarkers of disease, carry out biopsies or perform surgery.
By Nick Paul Taylor • Jan. 26, 2023 -
Courtesy of Abbott Laboratories
Abbott sees ‘signs of stability’ for 2023 as hospital staffing, supply chain improves
While the company continues to grapple with supply shortages and procedure restrictions, it sold more COVID-19 tests than expected in the fourth quarter.
By Elise Reuter • Jan. 25, 2023 -
Scott Olson via Getty Images
FDA weighs shift in COVID vaccination strategy
Agency scientists are proposing to update COVID shots once a year to match circulating coronavirus strains, as well as simplifying current vaccination regimens.
By Ned Pagliarulo • Jan. 23, 2023 -
Courtesy of Stanford University
Q&A3 questions for Michael Snyder, lead inventor of single-drop blood test
The head of a Stanford research team says the test differs from Theranos' defunct product because "ours works."
By Peter Green • Jan. 23, 2023 -
sorbetto via Getty Images
Stanford team reports progress with Theranos-like finger prick blood test
The researchers have created a system for capturing and analyzing thousands of molecules from a single drop of blood.
By Nick Paul Taylor • Jan. 23, 2023 -
Courtesy of Google Cloud
OpinionRealizing the promise of AI for medical imaging and diagnosis
Alissa Hsu Lynch, global lead for MedTech Strategy & Solutions at Google Cloud, explains how medtech companies can benefit from applying AI to the explosion of medical imaging data.
By Alissa Hsu Lynch, global lead for MedTech Strategy & Solutions at Google Cloud • Jan. 19, 2023 -
Adam Berry via Getty Images
CT scans offer new path to diagnose treatable cause of high blood pressure, study shows
While the approach could increase demand for CT imaging, the supply of radioactive tracers is potentially a barrier to adoption of the technique.
By Nick Paul Taylor • Jan. 19, 2023 -
Spencer Platt via Getty Images
Deep learning may improve triaging of people with acute chest pain, study shows
The researchers trained a model to find signs in scans that a person may have a serious cardiovascular condition.
By Nick Paul Taylor • Jan. 19, 2023 -
simonkr via Getty Images
Bayer to buy AI imaging platform Blackford Analysis to bolster radiology growth strategy
Bayer aims to outpace the broader radiology segment by investing in fast-growing technologies such as imaging AI.
By Elise Reuter • Updated Jan. 18, 2023 -
yodiyim via Getty Images
AI predicts lung cancer risk six years into the future using single CT scan: study
A research team has made the deep learning model publicly available and says it has no intention to commercialize it.
By Nick Paul Taylor • Jan. 17, 2023 -
Courtesy of Cue Health Press Kit
Cue Health lays off 388 people as demand falls for COVID-19 tests
Cue is reducing its headcount by 26% after laying off 170 employees last June.
By Nick Paul Taylor • Jan. 11, 2023 -
Courtesy of GuardantHealth
Guardant Health posts revenue growth in Q4 on higher clinical testing volumes
The oncology diagnostics company’s preliminary results beat analyst estimates.
By Nick Paul Taylor • Jan. 10, 2023 -
Courtesy of LabCorp
Labcorp hires ex-Quintiles CEO to lead clinical development unit ahead of upcoming spinoff
Thomas Pike, who oversaw the transformational merger of Quintiles and IMS Health, will be in charge of a CRO for the first time since 2016.
By Nick Paul Taylor • Jan. 6, 2023 -
Lisa Maree Williams via Getty Images
AstraZeneca extends C2i pact to validate minimal residual disease solid tumor blood test
The technology could improve cancer treatment and support clinical trial recruitment and monitoring.
By Nick Paul Taylor • Jan. 6, 2023 -
Courtesy of Illumina
Illumina signs new $750M credit agreement after bumpy year
The fallout from Illumina’s takeover of Grail and macroeconomic challenges have weighed on the company’s share price, which has fallen about 45% in the past 12 months.
By Nick Paul Taylor • Jan. 5, 2023 -
iStock via Getty Images
Roche receives first European IVDR certificate for companion diagnostic
Receipt of the certificate clears Roche to sell a companion diagnostic for immune checkpoint inhibitors in the European Union.
By Nick Paul Taylor • Jan. 5, 2023 -
Peter S Green/MedTech Dive
GE HealthCare starts trading on Nasdaq as independent company
The company’s stock gained in morning trading after debuting at $56 per share.
By Elise Reuter • Jan. 4, 2023 -
Permission granted by Freenome
Q&AFreenome CEO Mike Nolan talks colorectal cancer test, clinical trials
The San Francisco-based company recently enrolled a clinical trial for its blood-based cancer test but faces competition in the market for minimally invasive cancer tests.
By Elise Reuter • Dec. 22, 2022 -
Brendan Hoffman via Getty Images
Diagnostic testing reform missing from Congress’ year-end spending bill
A provision that would have brought in-vitro diagnostic tests and lab-developed tests under one regulatory framework was not included in the omnibus spending bill.
By Elise Reuter • Dec. 21, 2022 -
Courtesy of Odin Vision
Olympus agrees to $80M takeover of artificial intelligence endoscopy startup Odin Vision
The acquisition gives Olympus control of cloud-based AI systems to help detect and characterize cancerous and precancerous tissues during colonoscopies and gastroscopies.
By Nick Paul Taylor • Dec. 21, 2022 -
Fujifilm agrees to buy Inspirata’s Dynamyx in challenge to Philips for digital pathology market
Fujifilm struck the deal after customers told it “digitizing pathology will be the most transformative thing they do for their practice.”
By Nick Paul Taylor • Dec. 21, 2022 -
Pivotal data on Guardant’s colorectal cancer blood test raise doubts about commercial prospects
Guardant’s share price fell 27% after the release of the news, which raised questions about whether the test can drive sales growth.
By Nick Paul Taylor • Dec. 19, 2022
Previous
